Early trial results found median survival nearly doubled in ovarian cancer patients with addition of Elenagen
After two years, patients receiving gemcitabine and Elenagen survived twice as long as those treated with chemotherapy alone.
US women prefer clinic to at-home screening for cervical cancer
Most American women prefer to have their cervical cancer screening done by a professional in a doctor’s office despite the availability of newly FDA-approved at-home screening kits.
Combination mRNA cancer vaccine and Keytruda sustains recurrence-free survival at five years
Metastatic melanoma cells – Image Credit National Cancer Institute CANCER DIGEST – Jan. 24, 2026 – When a personalized mRNA cancer vaccine is added to an immunotherapy for the treatment of advanced melanoma, more patients survived without recurrence than those treated with pembrolizumab (Keytruda®) alone, the five-year updated results of a clinical trial show. The KEYNOTE-942 ongoing clinical trial ( NCT03897881 ) compares the effectiveness of treatment of patients with stage
Risk-based breast cancer screening may be more efficient than age-based guidelines
Individually-tailored risk-based screening may be a more efficient way to screen for breast cancer. Image credit – National Cancer Institute CANCER DIGEST – Jan. 18, 2026 – Tailoring breast cancer screening to individual risk factors as opposed to relying on age guidelines may be a better way to reduce the chance of advanced cancer at diagnosis, a major screening study shows. The WISDOM study enrolled 46,000 women from all 50 states between 2016 and 2023. The aim was to compa
Durvalumab boosts survival for small-cell lung cancer but at a high cost
A new cost/benefit analysis of an immunotherapy drug that showed significantly longer survival for people with an aggressive form of lung cancer, called small-cell lung cancer, concludes that the treatment might be too expensive to be worth it.
Short bouts of intensive exercise may help with colorectal cancer treatment
Short intensive periods of physical activity can unleash several molecules in the blood linked to reducing inflammation and improving blood vessel function and metabolism, which can slow colorectal cancer growth.
